We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATIP.WS
526
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$1.98K ﹤0.01%
75,500
+100
+0.1% +$3
FEXDW
527
DELISTED
Fintech Ecosystem Development Corp. Warrant
FEXDW
$1.95K ﹤0.01%
55,640
+31,050
+126% +$1.24K
ATMCW
528
DELISTED
AlphaTime Acquisition Corp Warrant
ATMCW
$1.94K ﹤0.01%
+43,007
New +$1.91K
UPH.WS
529
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$1.93K ﹤0.01%
96,697
-200
-0.2% -$6
FXCOW
530
DELISTED
Financial Strategies Acquisition Corp. Warrants
FXCOW
$1.93K ﹤0.01%
55,000
+5,000
+10% +$151
SHAP.WS
531
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$1.9K ﹤0.01%
63,000
– –
SHFSW icon
532
SHF Holdings Warrants
SHFSW
$241K
$1.84K ﹤0.01%
70,319
– –
NCACW
533
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$1.83K ﹤0.01%
55,000
+5,000
+10% +$213
APXIW
534
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$1.69K ﹤0.01%
+29,107
New +$1.36K
QDROW
535
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$1.6K ﹤0.01%
78,061
+59,224
+314% +$1.78K
REVBW icon
536
Revelation Biosciences Warrant
REVBW
$9.12K
$1.59K ﹤0.01%
+98,296
New +$2.47K
TLGYW
537
DELISTED
TLGY Acquisition Corporation Warrant
TLGYW
$1.53K ﹤0.01%
+18,500
New +$829
SKYAW
538
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
$1.52K ﹤0.01%
46,933
+5,167
+12% +$323
CSLMW
539
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
$1.52K ﹤0.01%
40,600
-25,100
-38% -$924
TFC icon
540
CALL
Truist Financial
TFC
$63.9B
$1.5K ﹤0.01%
+10,000
New +$437K
SCUA.WS
541
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$1.49K ﹤0.01%
14,900
-166,400
-92% -$19K
ACBAW
542
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$1.49K ﹤0.01%
35,000
-169
-0.5% -$9
COCHW icon
543
Envoy Medical Warrant
COCHW
$708K
$1.48K ﹤0.01%
39,240
-8,807
-18% -$495
BETRW icon
544
Better Home & Finance Warrant
BETRW
$1.85M
$1.45K ﹤0.01%
25,000
– –
ZEOWW
545
Zeo Energy Corp Warrants
ZEOWW
$93.1K
$1.44K ﹤0.01%
24,800
-3,490
-12% -$194
ADOCW
546
DELISTED
Edoc Acquisition Corp. Warrant
ADOCW
$1.42K ﹤0.01%
81,400
-100
-0.1% -$3
IGTAW
547
DELISTED
Inception Growth Acquisition Limited Warrants
IGTAW
$1.35K ﹤0.01%
53,723
– –
PRENW
548
Prenetics Global Ltd Warrant
PRENW
$113K
$1.34K ﹤0.01%
+12,955
New +$1.65K
GETR.WS
549
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$1.3K ﹤0.01%
27,659
+1,301
+5% +$73
ALTUW
550
DELISTED
Altitude Acquisition Corp Warrant
ALTUW
$1.28K ﹤0.01%
25,000
– –
20 21
22
23 24

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.